Mike Severino, CEO of Tessera Therapeutics and CEO-Partner at Flagship Pioneering explains the power of and recent progress in advancing Tessera’s Gene Writing platforms, including promising new data in non-human primates. More from Flagship @ JPM2023 here.
Related Companies
- Tessera Therapeutics Founded: 2018
